01 May 2022
01 May 2022
An assessment of short-acting β2-agonist (SABA) use and subsequent greenhouse gas (GHG) emissions in five European countries and the consequence of their potential overuse for asthma in the U.K.
01 May 2022
Medical workers’ views on how to provide support for COVID-19 survivors with ongoing symptom burden
01 May 2022
Perspectives of COVID-19 survivors in Kyrgyzstan on how best to support their recovery following infection
01 May 2022
Personalised medication adherence management in asthma and COPD: a review of effective interventions and development of a practical adherence toolkit
01 May 2022
Effectiveness of combining feedback about lung age or exhaled CO levels with very brief advice (VBA) and support for smoking cessation in primary care compared to giving VBA and support alone
01 May 2022
Effect of indacaterol/mometasone on lung function in adolescents versus overall patient population: PALLADIUM study
01 May 2022
Assessing the opinions of Healthcare Practitioners in low- and middle-income countries (LMIC) on ways to support people recovering from COVID-19: A Nigeria Study.
01 May 2022
Lower ICS dose effect on symptoms and rescue medication use of indacaterol/glycopyrronium/mometasone (IND/GLY/MF) medium-dose vs salmeterol/fluticasone (SAL/FLU) high-dose plus tiotropium (TIO): ARGON study
01 May 2022